Annual report pursuant to Section 13 and 15(d)

Income Taxes - Schedule of Components of the Company's Net Deferred Tax Assets (Details)

v3.22.4
Income Taxes - Schedule of Components of the Company's Net Deferred Tax Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets    
Amortization $ 200 $ 174
Capitalized Research and Development Costs 9,453 0
Deferred revenue 778 577
Deferred expenses 0 446
Reserves 824 647
Accrued expenses 509 369
Stock compensation 2,296 2,138
Lease liability 11,220 0
Net operating losses 33,690 27,846
Research and development credits 12,260 3,717
Other 254 74
Gross deferred tax assets 71,484 35,988
Less: Valuation allowance (59,514) (36,009)
Deferred tax liabilities    
Depreciation (464) 21
Acquired intangible assets (3,690) 0
Right-of-use assets (10,599) 0
Net deferred tax assets $ (2,783) $ 0